Report cover image

Clinical Trials - What to Expect in 2024 - A Preview of Trials Planned to Initiate and Estimated to Complete

Publisher GlobalData
Published Jan 09, 2024
Length 44 Pages
SKU # GBDT18475319

Description

Clinical Trials - What to Expect in 2024 - A Preview of Trials Planned to Initiate and Estimated to Complete


Summary

This report provides a preview of clinical trials that are planned to be initiated and projected to be completed in 2024.

Scope
  • The clinical trials data used for these analyses were extracted from GlobalData’s Clinical Trials Database. The data included planned clinical trials with a start date from January 1 to December 31, 2024, captured in the database as of December 15, 2023. The planned trials were analyzed and segmented by phase, single versus multinational trials, geography, sponsor type (industry versus non-industry), therapy area, indication, top sponsors, drug type, and DCT use. Clinical trials with an ongoing or planned status with an end date between January 1 and December 31, 2024, were also examined. The trials that are estimated to be completed in 2024 were split by phase, status, indication, sponsor type, top sponsors, geography and DCT use. In this report, a small number of Phase 0, Phase I/II, Phase II/III, and Phase III/IV trials were combined with Phase I, Phase II, Phase III, and Phase IV trials, respectively.
Reasons to Buy
  • Understand the planned trials landscape and trends for 2024
  • Provide early insight for studies expected to be completed in 2024
  • The 2024 trends of DCTs in both planned trials and trials to be completed

Table of Contents

44 Pages
Executive Summary
Introduction
Clinical Trials Planned to Initiate in 2024
Clinical Trials Estimated to Complete in 2024
Key Findings
Appendix
List of Figures
Figures 1 and 2: Planned Clinical Trials, by Phase and Sponsor Type
Figure 3: Planned Clinical Trials Top Industry Sponsors, by Phase
Figure 4: Planned Clinical Trials Top Non-Industry Sponsors, by Phase
Figure 5: Planned Clinical Trials Single Country or Multinational, by Sponsor Type and Phase
Figure 6: Planned Clinical Trials Regions, by Phase
Figure 7: Planned Clinical Trials Regions, by Phase and Distribution
Figure 8: Planned Clinical Trials Country, by Phase
Figure 9: Planned Clinical Trials Country, by Phase and Distribution
Figures 10 and 11: Planned Clinical Trials Primary Intervention Molecule Type, by Phase and Distribution
Figure 12: Planned Clinical Trials Top Therapy Areas, by Phase
Figure 13: Planned Clinical Trials Top Therapy Areas, by Phase and Distribution
Figure 14: Planned Clinical Trials Top Indications, by Phase
Figure 15: Planned Clinical Trials Top Indications, by Phase and Distribution
Figures 16 and 17: Total Planned Clinical DCT Trials, by Therapeutic Area
Figure 18: Estimated to Complete Clinical Trials, by Phase
Figures 19 and 20: Estimated to Complete Clinical Trials by Status, by Phase and Phase Distribution
Figure 21: Estimated to Complete Clinical Trials, by Sponsor Type and Phase
Figure 22: Estimated to Complete Clinical Trials, by Top Industry Sponsor and Phase
Figure 23: Estimated to Complete Clinical Trials, by Top Non-Industry Sponsor and Phase
Figure 24: Estimated to Complete Single Country or Multinational Clinical Trials, by Region
Figure 25: Estimated to Complete Clinical Trials, by Country
Figure 26: Estimated to Complete Clinical Trials, by Therapy Area and Phase
Figure 27: Estimated to Complete Clinical Trials, by Indication and Phase
Figures 28 and 29: Total Estimated to Complete DCT Clinical Trials, by Region and Single Country or Multinational
Figure 30: Estimated to Complete DCT Clinical Trials, by Therapy Area and Phase

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us